OssDsign AB AI Stock Analysis
Want to see SE:OSSD full AI Analyst Report?
OssDsign AB (OSSD) AI Stock Analysis
OssDsign AB
(Nasdaq OMX AB:OSSD)
The score is mainly held back by continued losses and persistent cash burn despite attractive gross margins and minimal leverage. Technicals are mixed (some near-term support but weak longer-term trend), and valuation is difficult to assess due to negative earnings and no dividend yield data.
OssDsign AB (OSSD) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 387.19M
- Dividend Yield
- ―
- Average Volume (3M)
- 237.57K
- Price to Earnings (P/E)
- -7.7
- Beta (1Y)
- -0.63
- Revenue Growth
- -11.89%
- EPS Growth
- -11.85%
- Country
- Sweden
- Employees
- 38
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
OssDsign AB Business Overview & Revenue Model
Company Description
OssDsign AB (publ) specializes in the innovation, manufacturing, and distribution of advanced implant and material technologies crucial for bone regeneration. The company operates across a broad international market, including Sweden, Germany, the Un...
OssDsign AB Financial Statement Overview
Summary
Strong gross margins and a low-debt balance sheet are positives, but the overall profile is constrained by persistent operating losses and ongoing negative operating/free cash flow. Recent TTM revenue decline and deteriorating TTM free cash flow further limit the score despite some improvement versus earlier periods.
Income Statement
34NegativeBalance Sheet
66PositiveCash Flow
29Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.51M | 180.16M | 133.94M | 112.16M | 56.98M | 31.73M |
| Gross Profit | 145.34M | 173.47M | 127.75M | 83.64M | 45.13M | 20.84M |
| EBITDA | -52.98M | -44.30M | -44.40M | -122.02M | -89.41M | -79.97M |
| Net Income | -50.95M | -50.99M | -49.66M | -130.49M | -99.39M | -93.92M |
Balance Sheet | ||||||
| Total Assets | 358.25M | 397.87M | 307.42M | 356.39M | 339.50M | 343.99M |
| Cash, Cash Equivalents and Short-Term Investments | 138.06M | 191.35M | 100.86M | 165.94M | 124.65M | 151.37M |
| Total Debt | 698.00K | 1.37M | 1.97M | 3.15M | 13.60M | 14.13M |
| Total Liabilities | 75.36M | 87.84M | 93.36M | 105.26M | 91.39M | 81.26M |
| Stockholders Equity | 282.89M | 310.03M | 214.06M | 251.13M | 248.11M | 262.72M |
Cash Flow | ||||||
| Free Cash Flow | -61.55M | -71.43M | -63.04M | -94.03M | -89.36M | -89.84M |
| Operating Cash Flow | -48.82M | -64.03M | -62.38M | -93.91M | -89.23M | -89.78M |
| Investing Cash Flow | -24.29M | -7.40M | -657.00K | -124.00K | -129.00K | -51.85M |
| Financing Cash Flow | -163.00K | 163.18M | -2.46M | 135.40M | 61.84M | 243.43M |
OssDsign AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:OSSD, the sentiment is Negative. The current price of 3.50 is above the 20-day moving average (MA) of 3.49, below the 50-day MA of 3.52, and below the 200-day MA of 4.46, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 48.09 is Neutral, neither overbought nor oversold. The STOCH value of 43.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:OSSD.
OssDsign AB Peers Comparison
Overall Rating
SE:XVIVO64Neutral
SE:BACTI.B53Neutral
SE:SEDANA49Neutral
SE:INTEG.B45Neutral
SE:OSSD45Neutral
SE:HEART44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 64Neutral | SEK 6.49B | 50.37 | 5.89% | ― | 17.83% | 330.94% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | SEK 537.92M | 85.28 | 1.93% | ― | -0.51% | ― | |
| 49Neutral | SEK 907.94M | -26.31 | -3.88% | ― | 0.42% | 15.03% | |
| 45Neutral | SEK 240.25M | -5.70 | -20.71% | ― | 1.43% | 4.98% | |
| 45Neutral | SEK 387.19M | -7.74 | ― | ― | -11.89% | -11.85% | |
| 44Neutral | SEK 134.27M | -2.23 | -54.68% | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:OSSD | OssDsign AB | 3.50 | -7.48 | -68.12% | |
| SE:XVIVO | Xvivo Perfusion AB | 206.00 | 42.50 | 25.99% | |
| SE:BACTI.B | Bactiguard Holding AB | 15.35 | -0.55 | -3.46% | |
| SE:INTEG.B | Integrum AB Class B | 8.19 | -0.04 | -0.49% | |
| SE:HEART | Scandinavian Real Heart AB | 15.80 | 1.50 | 10.50% | |
| SE:SEDANA | Sedana Medical AB | 9.14 | -0.37 | -3.89% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
